NR3C1 and diabetic kidney disease: In addition, podocyte-endothelial crosstalk regulated by glucocorticoid receptors is important for the glomerular health therefore, the search for the new safe non-steroidal GR agonists is needed for development of future generation medication against diabetic nephropathy [154] and such medications could have beneficial effects to COVID-19 patients.